C-fos Antisense Oligodeoxynucleotide Increases Formalin-induced Nociception and Regulates Preprodynorphin Expression
Overview
Affiliations
Rats, receiving an intrathecal pretreatment of oligodeoxynucleotide complementary to c-fos mRNA (antisense), showed no increases in Fos protein or preprodynorphin messenger RNA in the outer laminae of the lumbar spinal cord when challenged 4 h later with a 50 microliters intraplantar injection of 5% formalin. Animals pretreated with saline or sense oligodeoxynucleotide showed marked increases in Fos protein (2 h after formalin challenge) and preprodynorphin mRNA (20 h after formalin challenge) in the lumbar region of the cord ipsilateral to the side of the injection. The behavioural consequences of antisense pretreatment were an increase in the formalin-induced licking/biting responses during the tonic, but not the acute phase. These observations could be interpreted as representing a sequence of events beginning with the formalin-induced increase in the transcription factor Fos, which in turn increases the synthesis of preprodynorphin messenger RNA resulting in the production of the dynorphin opioid peptides which then exert a modulatory antinociceptive action.
Rahimi K, Abbaszadeh M, Bakhtazad S, Ghotbeddin Z Brain Commun. 2024; 6(6):fcae397.
PMID: 39568551 PMC: 11577613. DOI: 10.1093/braincomms/fcae397.
Antinociceptive effects of vitamin B-complex: A behavioral and histochemical study in rats.
Zarei S, Shahriari-Khalaji M, Andolina I, Behzadi G IBRO Neurosci Rep. 2023; 15:270-280.
PMID: 37860709 PMC: 10582472. DOI: 10.1016/j.ibneur.2023.09.005.
Pulsed Radiofrequency (PRF) of Pericapsular Nerves Group (PENG) in Chronic Hip Pain-A Case Report.
Jadon A Turk J Anaesthesiol Reanim. 2022; 49(6):490-493.
PMID: 35110031 PMC: 9472694. DOI: 10.5152/TJAR.2021.1080.
Batistaki C, Madi A, Karakosta A, Kostopanagiotou G, Arvaniti C Anesth Pain Med. 2022; 11(5):e112235.
PMID: 35075408 PMC: 8782194. DOI: 10.5812/aapm.112235.
Arvaniti C, Madi A, Kostopanagiotou G, Batistaki C Anesth Pain Med. 2020; 10(2):e96418.
PMID: 32754427 PMC: 7352942. DOI: 10.5812/aapm.96418.